Cancer News and Research

Latest Cancer News and Research

Researchers receive $5M grant from agency to advance stem cell technologies in segmental bone defects

A Cedars-Sinai team of researchers led by principal investigator Dan Gazit, PhD, DMD, has been awarded a $5.18 million grant from California's stem cell research agency to advance stem cell technologies in segmental bone defects, a complex medical problem caused by large portions of bone tissue loss.

30 Aug 2013

States search for, reap benefits from programs to lower health care costs

Bloomberg explores the heavy financial toll of caring for a loved one with a disability. In the meantime, as states like Minnesota, Oklahoma and Florida see slower health care cost growth through implementing novel programs, others like -- Nevada and Wisconsin -- search for the magic tonic to lower their own costs.

30 Aug 2013

Researchers receive $3M R01 award to test new approach to treating brain tumors

With a five-year, $3 million R01 award from the National Institutes of Health, through the National Cancer Institute, a team of researchers led by Gregory Fischer, PhD, assistant professor of mechanical engineering and robotics engineering at Worcester Polytechnic Institute and director of WPI's Automation and Interventional Medicine Laboratory, will test a new, minimally invasive approach to treating brain tumors that promises to accurately destroy malignant tissue while leaving surrounding tissue unaffected.

30 Aug 2013

Some insurers refusing to pay for proton-beam cancer therapy

Blue Shield of California joins two other insurers who contend that other cancer treatments are just as good, and far less expensive.

30 Aug 2013

LLS survey uncovers alarming lack of knowledge among U.S. adults about blood cancers

Less than one half (46%) of adults polled in a new survey believe that blood cancers are one of three leading causes of cancer death in the U.S. In fact, blood cancers are the third leading cause of cancer death, behind cancers of the respiratory system, including lung cancer, and cancers of the digestive system, including colorectal cancer.

30 Aug 2013

Scientists identify enzyme mutation that occurs in castration-resistant prostate cancer

The mutation occurs in the androgen-synthesizing enzyme 3βHSD1 in castration-resistant prostate cancer (CRPC), according to research published online today in Cell. This mutation enables the tumor to make its own supply of androgens, a hormone that fuels the growth of the prostate cancer.

30 Aug 2013

Scientists provide insights into compound that may prevent noise-related damage

Your mother was right when she warned you that loud music could damage your hearing, but now scientists have discovered exactly what gets damaged and how. In a research report published in the September 2013 issue of The FASEB Journal, scientists describe exactly what type of damage noise does to the inner ear, and provide insights into a compound that may prevent noise-related damage.

30 Aug 2013

BTNL2 gene mutation that impacts immune function increases risk of prostate cancer

A team of researchers led by Janet Stanford, Ph.D., of Fred Hutchinson Cancer Research Center has discovered that mutations in the gene BTNL2, which encodes a protein involved in regulating T-cell proliferation and cytokine production - both of which impact immune function - increase the risk of developing prostate cancer.

30 Aug 2013

Researchers find new form of imaging technology to diagnose different types of cancer

Researchers from University Hospitals Case Medical Center have published findings that a new form of imaging -- PET/MRI -- is promising for several types of cancer.

30 Aug 2013

Stem cell researchers receive Early Translational research awards from CIRM

Four prominent researchers from UCLA's Eli & Edythe Broad Center of Regenerative Medicine and Stem Cell Research have received Early Translational research awards totaling approximately $13 million from the California Institute for Regenerative Medicine (CIRM) the state stem cell agency. The UCLA researchers received four of the 12 total awards; no other applicant institution received more than one award.

30 Aug 2013

Blood test provides tool essential to trials of therapies for Huntington's disease

An assay designed to measure normal and abnormal forms of the huntingtin protein - the mutated form of which causes Huntington's disease - was successful in detecting levels of the mutant protein in a large multicenter study of individuals at risk for the devastating neurological disorder.

30 Aug 2013

Protein activated by inflammation converts glioblastoma multiforme cells to most aggressive form

A prominent protein activated by inflammation is the key instigator that converts glioblastoma multiforme cells to their most aggressive, untreatable form and promotes resistance to radiation therapy, an international team lead by researchers at The University of Texas MD Anderson Cancer Center reported online today in the journal Cancer Cell.

30 Aug 2013

New joint research effort examines unique manifestation of breast cancer in Kenya

Breast cancer is a major health problem worldwide and the incidence of the disease is rising across Africa. A new joint research effort between the University of Notre Dame's Eck Institute for Global Health and Harper Cancer Research Institute and a Kenyan doctoral student from Moi University is examining the unique manifestation of breast cancer in Kenya.

30 Aug 2013

Absence or presence of single protein can make cancer cells more or less susceptible to drugs

A new weakness has been discovered in cancer cells that may make them more susceptible to chemotherapy and other treatments. In a research report appearing in the September 2013 issue of The FASEB Journal, scientists identify the HDAC5 protein as being essential for the maintenance of structures, called telomeres, within cancer cells that promote cancer cells longevity.

30 Aug 2013

Researchers discover protein that may help predict breast cancer prognosis

Researchers have identified a protein that they believe may help predict breast cancer prognosis, potentially relieving thousands of women at low risk from having to undergo painful, oft-debilitating therapies, while insuring the most successful treatments for those at high risk. The research was published ahead of print in the journal Molecular and Cellular Biology.

30 Aug 2013

Albumin-bound paclitaxel has favorable risk–benefit profile in NSCLC

Albumin-bound paclitaxel plus carboplatin is an effective and well-tolerated first-line treatment in patients with advanced non-small-cell lung cancer, irrespective of histology, study results show.

29 Aug 2013

First Edition: August 29, 2013

Today's headlines include reports about ongoing fiscal fights surrounding efforts to raise the nation's debt limit and to defund the health law. Also, the White House enlists former President Bill Clinton to help spread the word about the overhaul.

29 Aug 2013

Researchers discover old cancer drug can be used to prevent rejection of transplanted tissue

Researchers at Lund University have unexpectedly discovered that an old cancer drug can be used to prevent rejection of transplanted tissue. The researchers now have high hopes that their discovery could lead to new treatments for both transplant patients and patients with autoimmune diseases.

29 Aug 2013

FDA approves NDA filing for ibrutinib inhibitor in two B-cell malignancies

Pharmacyclics, Inc. (Nasdaq: PCYC) today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing its New Drug Application (NDA) for the investigational oral Bruton's tyrosine kinase (BTK) inhibitor ibrutinib, for two B-cell malignancy indications: previously treated mantle cell lymphoma (MCL) and previously treated chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL).

29 Aug 2013

Many men find prostate cancer treatment as a big challenge

After fighting off prostate cancer and beginning the road to recovery, many men are finding the expense of cancer treatment is almost as big a challenge as the disease.

29 Aug 2013

Cancer News and Research

Latest Cancer News and Research

Researchers receive $5M grant from agency to advance stem cell technologies in segmental bone defects

States search for, reap benefits from programs to lower health care costs

Researchers receive $3M R01 award to test new approach to treating brain tumors

Some insurers refusing to pay for proton-beam cancer therapy

LLS survey uncovers alarming lack of knowledge among U.S. adults about blood cancers

Scientists identify enzyme mutation that occurs in castration-resistant prostate cancer

Scientists provide insights into compound that may prevent noise-related damage

BTNL2 gene mutation that impacts immune function increases risk of prostate cancer

Researchers find new form of imaging technology to diagnose different types of cancer

Stem cell researchers receive Early Translational research awards from CIRM

Blood test provides tool essential to trials of therapies for Huntington's disease

Protein activated by inflammation converts glioblastoma multiforme cells to most aggressive form

New joint research effort examines unique manifestation of breast cancer in Kenya

Absence or presence of single protein can make cancer cells more or less susceptible to drugs

Researchers discover protein that may help predict breast cancer prognosis

Albumin-bound paclitaxel has favorable risk–benefit profile in NSCLC

First Edition: August 29, 2013

Researchers discover old cancer drug can be used to prevent rejection of transplanted tissue

FDA approves NDA filing for ibrutinib inhibitor in two B-cell malignancies

Many men find prostate cancer treatment as a big challenge

Industry Focus eBook - Immunology (3rd edition) eBook

Advancing Motor Neuron Disease Diagnosis with Non-Invasive Ultrasound and AI

How agentic AI is reshaping laboratory workflows

Fourier 80: bringing benchtop NMR systems to the laboratory

Cancer News and Research

Latest Cancer News and Research

Industry Focus eBook - Immunology (3rd edition) eBook

Advancing Motor Neuron Disease Diagnosis with Non-Invasive Ultrasound and AI

How agentic AI is reshaping laboratory workflows

Fourier 80: bringing benchtop NMR systems to the laboratory

Newsletters you may be interested in